The odactra market research report is one of a series of new reports that provides odactra market statistics, including the odactra industry global market size, regional shares, competitors with the odactra market share, detailed odactra market segments, market trends, and opportunities, and any further data you may need to thrive in the odactra industry. This odactra market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The growth in the forecast period can be attributed to rising demand for various medications to cure illnesses, increasing number of hospitals, rising urbanization, increasing personalized medicines, and increasing environmental pollution. Major trends in the forecast period include technological advancements, personalized medicine, virtual clinical trials, digital treatment adherence tools, and improved allergen extract manufacturing.
The increasing prevalence of allergic diseases is expected to drive the growth of the Odactra market. Allergic diseases are caused by an abnormal immune reaction to substances that are usually harmless, known as allergens. Several factors contribute to the rising rates of allergies, including environmental changes, greater exposure to allergens, urbanization, and lifestyle and dietary changes. Odactra works through allergen-specific immunotherapy, which gradually exposes the immune system to dust mite allergens, helping to desensitize it. This process reduces allergic reactions, alleviates symptoms, and provides long-term relief for people with dust mite allergies. According to Allergy UK, as of April 2024, more than five million individuals in the UK require specialized care for severe allergies, and by 2026, at least half of the population in Europe is expected to be affected by allergies. This growing prevalence of allergic diseases is a key factor driving the demand for Odactra.
The increasing number of hospitals is also expected to boost the growth of the Odactra market. Hospitals provide essential healthcare services, including emergency care, surgery, and specialized treatments. The number of hospitals is rising due to factors such as increased healthcare demand, population growth, advances in medical technology, and more investments in healthcare infrastructure. With more hospitals offering specialized care, including immunotherapy for dust mite-induced allergic rhinitis, there will be greater access to treatments such as Odactra. In May 2023, the American Health Care Association reported that the U.S. had 6,129 hospitals, a 0.591% increase from the previous year. As the number of hospitals continues to rise, the demand for allergy treatments is also expected to grow.
A key trend in the Odactra market is the development of advanced allergy immunotherapy tablets, which aim to improve patient compliance and therapeutic outcomes. These oral treatments work by gradually desensitizing the immune system to specific allergens, reducing sensitivity and minimizing the severity of allergic reactions over time. For example, in January 2023, ALK-Abelló, a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved Odactra (House Dust Mite Allergen Extract) tablets for sublingual use in adolescents aged 12-17. Initially approved in 2017 for adults aged 18-65, this expanded approval allows Odactra to treat house dust mite-induced allergic rhinitis in individuals aged 12-65. While Odactra serves as immunotherapy for confirmed dust mite allergies, it is not intended for immediate symptom relief.
The countries covered in the odactra market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Odactra is an allergy immunotherapy treatment designed for allergic rhinitis triggered by dust mites. It works by gradually desensitizing the immune system to dust mite allergens, helping to reduce symptoms such as sneezing, runny nose, and itchy eyes. Odactra aims to provide long-term relief by modifying the immune system's response to these allergens over time.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary indications for Odactra are house dust mite-induced allergic rhinitis and allergic conjunctivitis. House dust mite-induced allergic rhinitis is an allergic condition that causes nasal inflammation, sneezing, itching, and congestion due to exposure to dust mites. Odactra is used for various age groups, including adults (18-65 years), adolescents (12-17 years), and children (5-11 years). It is distributed through multiple channels, including retail pharmacies, online pharmacies, and hospital pharmacies.
The odactra market consists of sales of tablets, allergy testing kits, sublingual immunotherapy (SLIT) delivery systems, and patient adherence tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth in the forecast period can be attributed to rising demand for various medications to cure illnesses, increasing number of hospitals, rising urbanization, increasing personalized medicines, and increasing environmental pollution. Major trends in the forecast period include technological advancements, personalized medicine, virtual clinical trials, digital treatment adherence tools, and improved allergen extract manufacturing.
The increasing prevalence of allergic diseases is expected to drive the growth of the Odactra market. Allergic diseases are caused by an abnormal immune reaction to substances that are usually harmless, known as allergens. Several factors contribute to the rising rates of allergies, including environmental changes, greater exposure to allergens, urbanization, and lifestyle and dietary changes. Odactra works through allergen-specific immunotherapy, which gradually exposes the immune system to dust mite allergens, helping to desensitize it. This process reduces allergic reactions, alleviates symptoms, and provides long-term relief for people with dust mite allergies. According to Allergy UK, as of April 2024, more than five million individuals in the UK require specialized care for severe allergies, and by 2026, at least half of the population in Europe is expected to be affected by allergies. This growing prevalence of allergic diseases is a key factor driving the demand for Odactra.
The increasing number of hospitals is also expected to boost the growth of the Odactra market. Hospitals provide essential healthcare services, including emergency care, surgery, and specialized treatments. The number of hospitals is rising due to factors such as increased healthcare demand, population growth, advances in medical technology, and more investments in healthcare infrastructure. With more hospitals offering specialized care, including immunotherapy for dust mite-induced allergic rhinitis, there will be greater access to treatments such as Odactra. In May 2023, the American Health Care Association reported that the U.S. had 6,129 hospitals, a 0.591% increase from the previous year. As the number of hospitals continues to rise, the demand for allergy treatments is also expected to grow.
A key trend in the Odactra market is the development of advanced allergy immunotherapy tablets, which aim to improve patient compliance and therapeutic outcomes. These oral treatments work by gradually desensitizing the immune system to specific allergens, reducing sensitivity and minimizing the severity of allergic reactions over time. For example, in January 2023, ALK-Abelló, a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved Odactra (House Dust Mite Allergen Extract) tablets for sublingual use in adolescents aged 12-17. Initially approved in 2017 for adults aged 18-65, this expanded approval allows Odactra to treat house dust mite-induced allergic rhinitis in individuals aged 12-65. While Odactra serves as immunotherapy for confirmed dust mite allergies, it is not intended for immediate symptom relief.
The key company operating in the odactra market is ALK Abello A/s
North America was the largest region in the odactra market in 2024. The regions covered in odactra report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.The countries covered in the odactra market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Odactra is an allergy immunotherapy treatment designed for allergic rhinitis triggered by dust mites. It works by gradually desensitizing the immune system to dust mite allergens, helping to reduce symptoms such as sneezing, runny nose, and itchy eyes. Odactra aims to provide long-term relief by modifying the immune system's response to these allergens over time.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary indications for Odactra are house dust mite-induced allergic rhinitis and allergic conjunctivitis. House dust mite-induced allergic rhinitis is an allergic condition that causes nasal inflammation, sneezing, itching, and congestion due to exposure to dust mites. Odactra is used for various age groups, including adults (18-65 years), adolescents (12-17 years), and children (5-11 years). It is distributed through multiple channels, including retail pharmacies, online pharmacies, and hospital pharmacies.
The odactra market consists of sales of tablets, allergy testing kits, sublingual immunotherapy (SLIT) delivery systems, and patient adherence tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Odactra Market Characteristics4. Odactra Market Trends And Strategies5. Odactra Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market7. Global Odactra Pricing Analysis & Forecasts30. Global Odactra Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Odactra Market32. Recent Developments In The Odactra Market
3. Odactra Market Biologic Drug Characteristics
6. Global Odactra Growth Analysis And Strategic Analysis Framework
8. Odactra Market Segmentation
9. Global Odactra Epidemiology Of Clinical Indications
10. Odactra Market Regional And Country Analysis
11. Asia-Pacific Odactra Market
12. China Odactra Market
13. India Odactra Market
14. Japan Odactra Market
15. Australia Odactra Market
16. South Korea Odactra Market
17. Western Europe Odactra Market
18. UK Odactra Market
19. Germany Odactra Market
20. France Odactra Market
21. Eastern Europe Odactra Market
22. North America Odactra Market
23. USA Odactra Market
24. Canada Odactra Market
25. South America Odactra Market
26. Middle East Odactra Market
27. Africa Odactra Market
28. Odactra Market Competitive Landscape And Company Profiles
29. Global Odactra Market Pipeline Analysis
33. Odactra Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Odactra Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on odactra market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for odactra ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The odactra market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Indication: House Dust Mite-Induced Allergic Rhinitis; Allergic Conjunctivitis2) By Age Group: Adults (18-65 Years); Adolescents (12-17 Years); Children (5-11 Years)
3) By Distribution Channel: Retail Pharmacies; Online Pharmacies; Hospital Pharmacies
Key Companies Profiled: ALK Abello A/s
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- ALK Abello A/s
